These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8952859)

  • 1. Thrombotic and hemorrhagic complications in chronic myeloproliferative disorders.
    Sagripanti A; Ferretti A; Nicolini A; Carpi A
    Biomed Pharmacother; 1996; 50(8):376-82. PubMed ID: 8952859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What vascular events suggest a myeloproliferative disorder?].
    Hachulla E; Rose C; Trillot N; Caulier-Leleu MT; Pasturel-Michon U
    J Mal Vasc; 2000 Dec; 25(5):382-387. PubMed ID: 11148402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
    Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of picotamide, a dual anti-thromboxane agent, in patients with thrombocytosis and a previous thromboembolic event: a 1-year observational study.
    Pogliani E; Milani M
    J Int Med Res; 1996; 24(3):311-5. PubMed ID: 8725994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin and platelet-lowering agents for the prevention of vascular complications in essential thrombocythemia.
    Michiels JJ
    Clin Appl Thromb Hemost; 1999 Oct; 5(4):247-51. PubMed ID: 10726022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia.
    Michiels JJ; van Genderen PJ; Lindemans J; van Vliet HH
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():47-56. PubMed ID: 8951772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients.
    Wehmeier A; Daum I; Jamin H; Schneider W
    Ann Hematol; 1991 Aug; 63(2):101-6. PubMed ID: 1912029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.
    Harrison CN; Campbell PJ; Buck G; Wheatley K; East CL; Bareford D; Wilkins BS; van der Walt JD; Reilly JT; Grigg AP; Revell P; Woodcock BE; Green AR;
    N Engl J Med; 2005 Jul; 353(1):33-45. PubMed ID: 16000354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic dilemmas: balancing the risks of bleeding, thrombosis, and leukemic transformation in myeloproliferative disorders (MPD).
    Murphy S
    Thromb Haemost; 1997 Jul; 78(1):622-6. PubMed ID: 9198227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin in essential thrombocythemia: status quo and quo vadis.
    Griesshammer M; Bangerter M; van Vliet HH; Michiels JJ
    Semin Thromb Hemost; 1997; 23(4):371-7. PubMed ID: 9263354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex intracranial vascular complications caused by essential thrombocythemia: a critical case report.
    Xie J; Geng L; Yuan B; Guo Y; Zhang Z
    BMC Neurol; 2020 Nov; 20(1):407. PubMed ID: 33158429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-mediated microvascular inflammation and thrombosis in thrombocythemia vera: a distinct aspirin-responsive arterial thrombophilia, which transforms into a bleeding diathesis at increasing platelet counts.
    Michiels JJ
    Pathol Biol (Paris); 2003 Apr; 51(3):167-75. PubMed ID: 12781799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal life expectancy and thrombosis-free survival in aspirin treated essential thrombocythemia.
    Michiels JJ
    Clin Appl Thromb Hemost; 1999 Jan; 5(1):30-6. PubMed ID: 10725980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
    Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
    Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effectiveness of anagrelide treatment in patients with Ph negative myeloproliferative diseases: influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with other myeloproliferative diseases treated with Thromboreductin® to the end of 2012].
    Penka M; Schwarz J; Ovesná P; Cervinek L; Dulíček P; Pospíšilová D; Kissová J; Pavlík T;
    Vnitr Lek; 2013 Jun; 59(6):516-31. PubMed ID: 23808749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anagrelide: 20 years later.
    Emadi A; Spivak JL
    Expert Rev Anticancer Ther; 2009 Jan; 9(1):37-50. PubMed ID: 19105705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical transient ischemic attacks in thrombocythemia of various myeloproliferative disorders.
    Michiels JJ; van Genderen PJ; Jansen PH; Koudstaal PJ
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():65-70. PubMed ID: 8951774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of picotamide, an antithromboxane agent, on carotid atherosclerotic evolution. A two-year, double-blind, placebo-controlled study in diabetic patients.
    Cocozza M; Picano T; Oliviero U; Russo N; Coto V; Milani M
    Stroke; 1995 Apr; 26(4):597-601. PubMed ID: 7709404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis.
    Cortelazzo S; Finazzi G; Ruggeri M; Vestri O; Galli M; Rodeghiero F; Barbui T
    N Engl J Med; 1995 Apr; 332(17):1132-6. PubMed ID: 7700286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin-responsive, migraine-like transient cerebral and ocular ischemic attacks and erythromelalgia in JAK2-positive essential thrombocythemia and polycythemia vera.
    Michiels JJ; Berneman Z; Gadisseur A; Lam KH; De Raeve H; Schroyens W
    Acta Haematol; 2015; 133(1):56-63. PubMed ID: 25116182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.